![[feed]](http://eprints.gla.ac.uk/style/images/feed-icon-14x14.png){kind=icon}
![[feed]](http://eprints.gla.ac.uk/style/images/twitter-logo.png){kind=logo}
Opong, K., Belaire-Franch, J., Hamill, P., and McIlkenny, P. (2013) Valuation implications of pharmaceutical companies R&D regulatory approval notifications. British Accounting Review . ISSN 0890-8389 (doi:10.1016/j.bar.2013.03.004) (In Press)
Full text not currently available from Enlighten.
| Item Type: | Article |
|---|---|
| Status: | In Press |
| Refereed: | Yes |
| Glasgow Author(s): | Opong, Prof Kwaku |
| Authors: | Opong, K., Belaire-Franch, J., Hamill, P., and McIlkenny, P. |
| College/School: | College of Social Sciences > Adam Smith Business School > Accounting and Finance |
| Journal Name: | British Accounting Review |
| Publisher: | Elsevier |
| ISSN: | 0890-8389 |
| ISSN (Online): | 1095-8347 |
| Published Online: | April 2013 |
University Staff: Request a correction | Enlighten Editors: Update this record
Tools
Tools